TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32986097

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) group; instructed to eat ad libitum from 12:00 pm until 8:00 pm and abstain from caloric intake from 8:00 pm until 12:00 pm the following day
Number of subjects: 116

Group type: COMPARATOR
Intervention: Consistent meal timing (CMT) group; instructed to eat 3 structured meals per day
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) group (in-person cohort)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Comparison of appendicular lean mass index between groups
Number of subjects: 116
Study: 35110687

Group type: EXPERIMENTAL
Intervention: intermittent theta-burst stimulation
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: high-frequency rTMS of the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 268
Study: 33422006

Group type: EXPERIMENTAL
Intervention: Cumulative bevacizumab doses (various metrics including cumulative dose, quantiles of cumulative dose, standardized cumulative dose, Theoretical Blood Concentration (TBC), and Weighted Cumulative Exposure (WCE))
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Cumulative bevacizumab doses
Number of subjects: 382
Study: 34706211

Group type: EXPERIMENTAL
Intervention: Resistance training for 6 months
Number of subjects: 30
Study: 33226845

Group type: EXPERIMENTAL
Intervention: KOOS Symptoms
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: KOOS Pain
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: KOOS Activities of Daily Living (ADL)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: KOOS Sports and Recreation
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: KOOS Quality of Life (QOL)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: IKDC
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Lysholm
Number of subjects: 113
Study: 32912157

Group type: EXPERIMENTAL
Intervention: Sildenafil (25 mg TID for 3 months followed by 50 mg TID for 3 months; n=30)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 50
Study: 33822654

Group type: EXPERIMENTAL
Intervention: Speech therapy services for 30 min twice weekly
Number of subjects: 35

Group type: COMPARATOR
Intervention: Speech therapy services for 15 min 4 times weekly
Number of subjects: 35
Study: 33386845

Group type: EXPERIMENTAL
Intervention: Patients with RHD
Number of subjects: 15400

Group type: COMPARATOR
Intervention: Patients without RHD
Number of subjects: 15400

Group type: EXPERIMENTAL
Intervention: CHA2DS2‐VASc score performance in patients with RHD
Number of subjects: 15400

Group type: COMPARATOR
Intervention: CHA2DS2‐VASc score performance in patients without RHD
Number of subjects: 15400

Group type: EXPERIMENTAL
Intervention: Mitral stenosis
Number of subjects: 15400
Study: 32223524

Group type: EXPERIMENTAL
Intervention: TSEgest
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RPSFTM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TSEsimp
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPCW
Number of subjects: 0
Study: 34115578

Group type: EXPERIMENTAL
Intervention: Video of a clinician performing the neurologic examination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Handout about the neurologic exam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no supplemental activities)
Number of subjects: 0
Study: 34751672

Group type: EXPERIMENTAL
Intervention: COVID-19 patients (575 patients)
Number of subjects: 871

Group type: COMPARATOR
Intervention: Control group (296 patients)
Number of subjects: 871
Study: 34858021

Group type: EXPERIMENTAL
Intervention: Advanced dental cleaning
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (dental examination only)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Microbiome analysis
Number of subjects: 101
Study: 32673591

Group type: EXPERIMENTAL
Intervention: 4-h Time-Restricted Feeding (TRF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6-h Time-Restricted Feeding (TRF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no meal timing restrictions)
Number of subjects: 0
Study: 34320865

Group type: EXPERIMENTAL
Intervention: PECS-1 block with 0.4 mL kg−1 0.25% bupivacaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PECS-1 block
Number of subjects: 120

Group type: COMPARATOR
Intervention: Infiltration anesthesia with 0.4 mL kg−1 0.25% bupivacaine
Number of subjects: 120
Study: 36398740

Group type: EXPERIMENTAL
Intervention: Mechanical power (MP) of ventilation
Number of subjects: 1962
Study: 32761737

Group type: EXPERIMENTAL
Intervention: Low glycaemic index (LGI) diet (dietary GI = 40)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low glycaemic index (LGI) diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: High glycaemic index (HGI) diet (dietary GI = 60)
Number of subjects: 14
Study: 34571187

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 30 mL of 0.375% ropivacaine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham block with 30 mL of 0.9% saline
Number of subjects: 68
Study: 34060942

Group type: EXPERIMENTAL
Intervention: Any intracranial hemorrhage
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Parenchymal hematoma type 1 (PH1)
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Parenchymal hematoma type 2 (PH2)
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Hemorrhagic infarction
Number of subjects: 1097
Study: 32664105

Group type: COMPARATOR
Intervention: Conventional dose group A (120 kVp, 150 mAs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low dose group B (120 kVp, 50 mAs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low dose group C (100 kVp, 50 mAs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low dose group D (100 kVp, 30 mAs)
Number of subjects: 60
Study: 34871344

Group type: COMPARATOR
Intervention: MMS
Number of subjects: 3332

Group type: COMPARATOR
Intervention: MQ-LNS
Number of subjects: 3332
Study: 32132005

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 10426
Study: 32303442

Group type: EXPERIMENTAL
Intervention: AP radiomics model
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: PP radiomics model
Number of subjects: 132
Study: 32980589

Group type: EXPERIMENTAL
Intervention: High loading condition (target +5% vertical ground reaction force)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low loading condition (target -5% vertical ground reaction force)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition (no cue)
Number of subjects: 12
Study: 33728558

Group type: EXPERIMENTAL
Intervention: Cascading Model
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Learning Collaborative
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Distance Education
Number of subjects: 150

Group type: COMPARATOR
Intervention: Consultation calls
Number of subjects: 150
Study: 32556601

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 36
Study: 34759247

Group type: EXPERIMENTAL
Intervention: Immediate surgery after chemotherapy (arm A)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Standard radiochemotherapy (capecitabine 50) plus surgery (arm B)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Capecitabine 50 (arm C)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Intensive radiochemotherapy (capecitabine 60; 60 Gy irradiation) (arm D)
Number of subjects: 206
Study: 33439748

Group type: EXPERIMENTAL
Intervention: LEN and EPO alfa
Number of subjects: 195

Group type: COMPARATOR
Intervention: LEN alone
Number of subjects: 195
Study: 616593976

Group type: EXPERIMENTAL
Intervention: Team Nutriathlon (intervention group)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 404
Study: 34930648

Group type: EXPERIMENTAL
Intervention: BariBoard™
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control (no BariBoard™)
Number of subjects: 201
Study: 32393214

Group type: EXPERIMENTAL
Intervention: Individual health counseling based on the transtheoretical model (TTM) for weight loss, lasting 6 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Usual care (comparison group)
Number of subjects: 86
Study: 35081010

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg twice daily for 48 hours)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 80
Study: 33640257

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy (inhalation for five minutes, three times a week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 0
Study: 35492241

Group type: EXPERIMENTAL
Intervention: LEAP2 infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LEAP2 dosing in wild-type mice
Number of subjects: 20

Group type: COMPARATOR
Intervention: GHSR-null mice
Number of subjects: 20
Study: 34642836

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33926724

Group type: EXPERIMENTAL
Intervention: Fault detection performance index based on stochastic robustness/sensitivity ratio; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fault detection threshold setting algorithms using Randomized Algorithms; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 32029684

Group type: EXPERIMENTAL
Intervention: Simultaneous group (PCV13, DTaP, and IIV4 at visit 1)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Sequential group (PCV13 and DTaP at visit 1, IIV4 at visit 2)
Number of subjects: 221
Study: 33780999

Group type: EXPERIMENTAL
Intervention: Implementation of USPSTF guidelines for adolescent obesity management
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Flexibility within weight management programs
Number of subjects: 18
Study: 33327339

Group type: EXPERIMENTAL
Intervention: Individualized diabetes education
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study: 35599143

Group type: EXPERIMENTAL
Intervention: Individual Early Warning Score (I‐EWS)
Number of subjects: 90464

Group type: COMPARATOR
Intervention: National Early Warning Score (NEWS)
Number of subjects: 90464
Study: 33413707

Group type: EXPERIMENTAL
Intervention: Overall Glycaemic Index (GI)
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Overall Glycaemic Load (GL)
Number of subjects: 734
Study: 32243660

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) + Game therapy (GT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT) isolated
Number of subjects: 32
Study: 35325969

Group type: EXPERIMENTAL
Intervention: Hypochloric acid (100 μg/mL)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Hypochloric acid (1, 2, 4, 8 times of MBEC)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Povidone iodine (50 mg/mL)
Number of subjects: 41
Study: 32459885

Group type: EXPERIMENTAL
Intervention: Opicapone 25 mg tablet
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Opicapone 50 mg tablet
Number of subjects: 48

Group type: COMPARATOR
Intervention: Opicapone 25 mg capsule
Number of subjects: 48

Group type: COMPARATOR
Intervention: Opicapone 50 mg capsule
Number of subjects: 48
Study: 32619857

Group type: EXPERIMENTAL
Intervention: Registry-based RCTs
Number of subjects: 1000
Study: 35213293

Group type: EXPERIMENTAL
Intervention: Respond to Prevent intervention (integrated educational toolkits and streamlined materials)
Number of subjects: 175
Study: 33043697

Group type: COMPARATOR
Intervention: SET3
Number of subjects: 38

Group type: COMPARATOR
Intervention: SET1
Number of subjects: 38
Study: 34609490

Group type: EXPERIMENTAL
Intervention: High VZV circulation countries
Number of subjects: 17

Group type: COMPARATOR
Intervention: Moderate VZV circulation countries
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low VZV circulation countries
Number of subjects: 17
Study: 33016680

Group type: EXPERIMENTAL
Intervention: Exoskeleton (ExoAtlet) rehabilitation exercises (5 days a week for 2 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Active-passive pedal exercise bike rehabilitation exercises (5 days a week for 2 weeks)
Number of subjects: 47
Study: 33938704

Group type: EXPERIMENTAL
Intervention: Proactive management with Cal/BD foam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive management with Cal/BD foam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proactive management during remission periods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive management during remission periods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proactive management during relapse periods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive management during relapse periods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proactive management for patients who dropped out
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive management for patients who dropped out
Number of subjects: 0
Study: 34689288

Group type: EXPERIMENTAL
Intervention: Combination therapy (oral prednisolone 60 mg daily with gradual taper-off to 35 mg/day and cyclosporine 3 mg/kg/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Corticosteroid therapy (methylprednisolone 1000 mg for 3 days followed by oral prednisolone)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Corticosteroid therapy
Number of subjects: 70
Study: 32014538

Group type: EXPERIMENTAL
Intervention: Mother-Child Education Program (MOCEP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 106
Study: 34309576

Group type: EXPERIMENTAL
Intervention: eB2 app users (24 participants, 31%)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: eB2 app users
Number of subjects: 77

Group type: COMPARATOR
Intervention: Nonusers (53 participants, 69%)
Number of subjects: 77
Study: 34468079

Group type: EXPERIMENTAL
Intervention: Small-intestinal release peppermint oil
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 35120773

Group type: EXPERIMENTAL
Intervention: Screen-detected prostate cancer (PC)
Number of subjects: 10000
Study: 32598793

Group type: EXPERIMENTAL
Intervention: Enisamium iodide with symptomatic therapy
Number of subjects: 134

Group type: COMPARATOR
Intervention: Symptomatic therapy only (Control)
Number of subjects: 134
Study: 35110688

Group type: EXPERIMENTAL
Intervention: THC (7.5, 15 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33315812

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (50%-70% of heart rate reserve, 3-4 days/week for 25-40 min)
Number of subjects: 59

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 59
Study: 34969411

Group type: EXPERIMENTAL
Intervention: Breathing meditation training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine training
Number of subjects: 40
Study: 33051039

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Music Therapy-Based Stress Reduction (MTSR)
Number of subjects: 158
Study: 35601567

Group type: EXPERIMENTAL
Intervention: Nursing intervention based on health belief model (HBM)
Number of subjects: 60
Study: 33377716

Group type: EXPERIMENTAL
Intervention: Priligy (dapoxetine hydrochloride) 30 mg 1-3 hours before sexual activity combined with behavioral therapy and psychological counseling (30 minutes, once a month for two times)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Priligy (dapoxetine hydrochloride) 30 mg 1-3 hours before sexual activity
Number of subjects: 202
Study: 34836715

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with 12‐h time restricted feeding
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mediterranean diet without time restricted feeding
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard Australian Dietary Guidelines (ADG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups (MedDiet with/without TRF and ADG)
Number of subjects: 120
Study: 33993795

Group type: EXPERIMENTAL
Intervention: Reperfusion therapy
Number of subjects: 415

Group type: COMPARATOR
Intervention: No reperfusion
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Core volume
Number of subjects: 415
Study: 32755831

Group type: EXPERIMENTAL
Intervention: Smartphone-based lifestyle modification intervention using the DIAGURU mobile application for 6 months.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (non-intervention).
Number of subjects: 300
Study: 36412415

Group type: EXPERIMENTAL
Intervention: 6 cycles of single agent, 3 weekly injection paclitaxel 175 mg/m2 as maintenance therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 300
Study: 34684429

Group type: EXPERIMENTAL
Intervention: L-carnitine tartrate supplementation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35733135

Group type: EXPERIMENTAL
Intervention: VR Basic Life Support (BLS) training
Number of subjects: 88
Study: 33400778

Group type: EXPERIMENTAL
Intervention: Adjuvanted trivalent influenza vaccine (aTIV)
Number of subjects: 777

Group type: COMPARATOR
Intervention: Trivalent influenza vaccine (TIV)
Number of subjects: 777
Study: 36215334

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) + snail control
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) alone
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) + behavioral change interventions
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 176
Study: 32840412

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg daily for seven days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Roxithromycin (300 mg daily for seven days)
Number of subjects: 20
Study: 33932114

Group type: EXPERIMENTAL
Intervention: Intermittent ADT (IADT)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Continuous ADT (CADT)
Number of subjects: 303
Study: 32502243

Group type: EXPERIMENTAL
Intervention: High phosphorus intake (≥ 1375 mg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low phosphorus intake (< 1100 mg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Very high calcium intake
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Very low calcium intake
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Increased Ca/P ratio
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Decreased Ca/P ratio
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nutritional intake of phosphorus and calcium
Number of subjects: 20
Study: 36163662

Group type: EXPERIMENTAL
Intervention: Community-based care (1-week hospitalisation)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Hospital-based care (2 months hospitalisation)
Number of subjects: 425
Study: 34273973

Group type: EXPERIMENTAL
Intervention: Active 1 + FUN program
Number of subjects: 171

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 171
Study: 35643173

Group type: EXPERIMENTAL
Intervention: CADe device
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: CADe arm
Number of subjects: 1359
Study: 34531712

Group type: EXPERIMENTAL
Intervention: Multi-component intervention (diet and physical activity)
Number of subjects: 1641
Study: 32187075

Group type: EXPERIMENTAL
Intervention: Survey respondents (women and URM members)
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: Survey respondents (women)
Number of subjects: 927

Group type: COMPARATOR
Intervention: Survey respondents (men)
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: Survey respondents
Number of subjects: 927
Study: 35074433

Group type: EXPERIMENTAL
Intervention: DWI-guided DP-IMRT
Number of subjects: 260
Study: 33465274

Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation Program (CRP), nine-week course starting day 40±5 post-AuSCT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation Program (CRP)
Number of subjects: 32
Study: 35820656

Group type: EXPERIMENTAL
Intervention: Cookstove intervention
Number of subjects: 230
Study: 34892575

Group type: EXPERIMENTAL
Intervention: Spatially Distributed Sequential Stimulation (SDSS)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Constant Frequency Trains (CFTs) at 30Hz
Number of subjects: 1

Group type: COMPARATOR
Intervention: Constant Frequency Trains (CFTs) at 40Hz
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Doublet Frequency Trains (DFTs)
Number of subjects: 1
Study: 33535924

Group type: EXPERIMENTAL
Intervention: Low-level training group
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: High-level training group
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 175
Study: 33074695

Group type: EXPERIMENTAL
Intervention: Advantaged group (received more resources)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Disadvantaged group (received fewer resources)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Advantaged children over time
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both groups (advantaged and disadvantaged)
Number of subjects: 176
Study: 36114990

Group type: EXPERIMENTAL
Intervention: MYL-1601D
Number of subjects: 478

Group type: COMPARATOR
Intervention: Ref-InsAsp-US
Number of subjects: 478
Study: 33693678

Group type: EXPERIMENTAL
Intervention: Presence of any majority DRM
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Presence of any majority DRM with <2 active drugs
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Presence of minority variants (MVs) alone
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Inclusion of pre-ART MVs with majority DRMs
Number of subjects: 178
Study: 32901239

Group type: EXPERIMENTAL
Intervention: Fiberglass 'Figaro' crowns
Number of subjects: 10

Group type: COMPARATOR
Intervention: Preformed metal crowns (PMCs)
Number of subjects: 10
Study: 36155982

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT scans
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard-dose CT scans
Number of subjects: 93

Group type: COMPARATOR
Intervention: Low-dose CT scans
Number of subjects: 93